结核性胸膜炎激素应用与否的评价

Evaluation of the effects of glucoconticoid hormone on the treatment of tuberculous pleurisy

目的 探讨结核性胸膜炎的最佳治疗方法。方法 回顾分析我院从 1994年 1月至 2 0 0 4年 1月 5 0 2例结核性胸膜炎患者的治疗与疗效。结果 加用激素组 1月内胸水吸收的例数为 342例 (占 97% ) ,未加用激素组86例 (占 5 8% ) (P<0 .0 5 )。结论 早期在有效抗痨加抽液的基础上加用激素有助于加快胸水吸收。

Objective To explore the best treatment method for tuberculous pleurisy.Methods The clinical data of 502 tuberculous pleurisy patients admitted to our hospital between January 1994 and January 2004 were reviewed and analyzed. Among them, 352 were given glucoconticoid hormone and 149 were not. The one-month absorption rate of pleural effusion was compared between the two groups. Results The absorption rate of pleural effusion after the one-month treatment for the glucoconticoid hormone group was 97% and for the other group it was 58%: P < 0.05.Conclusion The early use of glucoconticoid hormone, in addition to the regular treatment of anti-tuberculosis therapy and draining pleural effusion, helps the absorption of pleural effusion.